Company Filing History:
Years Active: 2017
Title: Innovations in Bipolar Disorder Treatment: The Contributions of Ming Ta Michael Lee
Introduction
Ming Ta Michael Lee, an accomplished inventor based in Taipei, Taiwan, has made significant strides in the field of medical research, particularly focusing on bipolar disorder. With his innovative approach, Lee has contributed to understanding how genetic factors can influence treatment responses in patients with this mental health condition.
Latest Patents
Ming Ta Michael Lee holds a notable patent titled "Genetic variants associated with lithium response in bipolar disorder." This patent describes a method for determining lithium responsiveness in patients suffering from bipolar disorder. The method includes obtaining a sample from the patient and assaying it for the presence of specific glutamate decarboxylase-like 1 (GADL1) gene variants. Notably, the GADL1 gene variants encompass a T allele of the single nucleotide polymorphism (SNP) rs17026688, a G allele of the SNP rs17026651, and GADL1 1VS8+48delG. The presence of these gene variants indicates that the patient is likely to respond positively to lithium treatment, which can be a crucial factor in managing their condition effectively.
Career Highlights
Ming Ta Michael Lee's career is closely associated with Academia Sinica, a prestigious research institution where he engages in advanced studies and collaborations that foster innovation. His commitment to research and development is evident in his published works and contributions to the scientific community.
Collaborations
Throughout his career, Lee has collaborated with esteemed colleagues, including Andrew Tai-Ann Cheng and Yuan-Tsong Chen. These partnerships have enriched his research endeavors and contributed to significant advancements in understanding the genetic factors affecting mental health treatments.
Conclusion
Ming Ta Michael Lee's pioneering work on genetic variants associated with lithium responsiveness highlights the importance of personalized medicine in treating bipolar disorder. His innovations not only enhance our understanding of genetic influences on treatment efficacy but also pave the way for more effective therapeutic strategies. As the medical community continues to explore these breakthroughs, Lee's contributions will undoubtedly play a vital role in shaping future approaches to mental health treatment.